Clinical epidemiology of Long Covid/Post-Covid-Syndrom - a validation study

• Conditions: U09.9; Post COVID-19 condition, unspecified

• Registration Number: DRKS00027362
• Lead Sponsor: niversitätsklinikum Freiburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-05-14
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 1558

Inclusion Criteria

Previous participation in EPILOC Phase 1 and willingnesse (consent in writing) to participate in EPILOC Phase 2 and use information from EPILOC Phase 1
- Presence of Post-Covid syndrome or freedom of symptoms during EPILOC Phase 1

Exclusion Criteria

- Inability to attend the outpatient medical examination

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cardiorespiratory or cognitive functional deficits in subjects with persistent Post-Covid syndrome at least 12 months after acute infection

Secondary Outcome Measures

Name	Time	Method
- clinically relevant abnormal laboratory values<br>- frequency of exertional intolerance (expressed as PEM >14 h)<br>- frequency of genetic variants associated with persistent Post-Covid syndrome <br>- symptomatic improvement in comparison with information provided in Phase 1